Free On-line Access

SPCI - Sociedade Portuguesa de Cuidados Intensivos

Revista Brasileira de Terapia Intensiva

AMIB - Associação de Medicina Intensiva Brasileira

OFFICIAL JOURNAL OF THE ASSOCIAÇÃO BRASILEIRA DE MEDICINA INTENSIVA AND THE SOCIEDADE PORTUGUESA DE CUIDADOS INTENSIVOS

ISSN: 0103-507X
Online ISSN: 1982-4335

Ícone Fechar

How to Cite


 

Rezende E, Ferez MA, Silva Junior JM, Oliveira AMRR, Viana RAPP, Mendes CL, et al. Utilização de sistema fechado para coleta de sangue e necessidade de transfusão em pacientes graves. Rev Bras Ter Intensiva. 2010;22(1):5-10

 

 

2010;22(1):5-10
Original Article

http://dx.doi.org/10.1590/S0103-507X2010000100003

Closed system for blood sampling and transfusion in critically ill patients

Utilização de sistema fechado para coleta de sangue e necessidade de transfusão em pacientes graves

Ederlon RezendeI, Marcus Antonio FerezII, João Manoel da Silva JuniorI, Amanda Maria Ribas Rosa de OliveiraIII, Renata Andréa Pietro Pereira VianaIV, Ciro Leite MendesV, Diogo de Oliveira ToledoVI, Miguel Costa Ribeiro NetoIV, Tatiane Akemi SetoyamaIV

IPhysician of the Intensive Care Service of Hospital do Servidor Público Estadual "Francisco Morato de Oliveira" HSPE-FMO - São Paulo (SP), Brazil
IIPhysician of Intensive Care Unit of Hospital São Francisco - Ribeirão Preto (SP), Brazil
IIIResident Physician in Intensive Care Medicine of the Intensive Care Service of Hospital do Servidor Público Estadual "Francisco Morato de Oliveira" HSPE-FMO - São Paulo (SP), Brazil
IVNurse of the Intensive Care Service of Hospital do Servidor Público Estadual "Francisco Morato de Oliveira" HSPE-FMO - São Paulo (SP), Brazil
VPhysician of the Intensive Care Unit of Hospital de Emergência e Trauma Senador Humberto Lucena - João Pessoa (PB), Brazil
VIPhysician of the Intensive Care Service of Hospital do Servidor Público Estadual "Francisco Morato de Oliveira" HSPE-FMO - São Paulo (SP), Brazil

Conflicts of interest: Edwards Lifesciences (Irvine-CA) supplied the closed systems for blood sampling (VAMP® - Venous Arterial Blood Management Protection). No financial support was involved.

Submitted on October 29, 2009
Accepted on March 17, 2010

Corresponding author:

Amanda Maria Ribas Rosa de Oliveira
Rua Pedro de Toledo, 1800-6º andar - Vila Clementino
CEP: 04039-901 - São Paulo (SP), Brazil.
Fone/Fax: (11) 5088-8146
Email: [email protected]

 

Abstract

OBJECTIVE: Anemia is common in severely ill patients, and blood sampling plays a relevant causative role. Consequently, blood transfusions are frequent an related to several complications. Trying to reduce the transfusion-related risk, minimizing blood loss is mandatory. Thus, this work aimed to evaluate a closed blood sampling system as a strategy to spare unnecessary blood losses and transfusions.
METHODS: This was a prospective, randomized, controlled, multicenter, 6 months, clinical trial. The patients were assigned to either VAMP (Venous Arterial Blood Management Protection) group, using a closed blood sampling system, or control group. The groups' transfusion rate, as well as hemoglobin (Hb) and Hematocrit (Ht) changes were compared for 14 days.
RESULTS: Were included 127 patients, 65 assigned to the control group, and 62 to VAMP. During the intensive care unit stay, both groups experienced both hemoglobin and hematocrit drops. However, when the final Ht and Hb were compared between the groups, a difference was identified with higher values in the VAMP group (p=0.03; p=0.006, respectively). No statistical difference was found for both groups transfusion rates, although the VAMP group had an absolute 12% blood transfusion reduction.
CONCLUSION: The use of a closed blood sampling system was able to minimize blood count values changes, however failed to reduce transfusions rate.

Keywords: Anemia, Blood transfusion, Blood specimen collection, Intensive care unit

 

 

INTRODUCTION

Blood or blood components transfusion is a frequent procedure in severely ill patients, and its main rationale is to increase tissue oxygen availability.(1) It is however important to bear in mind the hemotherapy-related effect, for sensibly prescribing this therapy. Thus, the blood transfusion decision should be guided by precise diagnosis, based both on low hemoglobin values and on perfusion indicators.(2,3) Transfused patients have increased mortality both in the intensive care unit (ICU) and hospital, increased infection rates, organ failures, and longer ICU stays.(4-6)

Anemia is common in severely ill patients, and several causes contribute for its development and persistence, such as gastrointestinal bleeding, sepsis, renal failure and red blood cells changes.(7) Frequent blood sampling plays a relevant role in this process.(8) The transfusion threshold is currently around 7 g/dL hemoglobin, with this evidence supported by a study comparing two transfusion strategies (liberal versus restrictive) in severely ill anemic patients.(9)

Attempting to reduce the transfusion-associated risk, blood losses should be minimized, such as phlebotomy losses which mount up to 41 mL/daily.(10) Thus, the use of closed blood sampling systems in ICU looks reasonable, however these devices actual benefits on blood transfusions reduction is so far not clear.

Thus, this trial primary objective was to compare the rates of transfused patients and the number of packed red blood cells units used for the closed blood sampling system group versus control. In addition, to compare the groups' hemoglobin and hematocrit changes.

 

METHODS

After the institutions' Ethics Committees approval, this multicenter, prospective, randomized by chart clinical trial was conducted in the three hospitals' ICUs for 6 months.

Patients with arterial catheter (MBP) and/or a central venous line (CLV) for blood sampling, > 24 hours mechanic ventilation patients included within the first 48 hours from ICU admission and with a signed informed consent form were included. Were excluded patients younger than 18 years old, moribund or with low 30 days life expectation, and those with no-treating decision by the family; were also excluded patients admitted to the ICU with upper digestive hemorrhage, primary hematological diseases and Jehovah's Witnesses.

The patients were assigned to one of two groups, either VAMP or control. In the VAMP group, patients received a closed system for blood sampling (VAMP®-Venous Arterial Blood Management Protection, Edwards Lifesciences, Irvine, USA), adapted to the arterial or central venous lines. All laboratory tests blood samples were collected from the VAMP® closed system, which avoids discarding blood before laboratory sampling.

The control group patients remained without the closed blood sampling system. All laboratory samples were collected from the arterial and/or central venous catheter, and thus an initial volume was discarded in the sampling process.

Exceptionally for both groups, blood culture samples were collected by venous puncture. Daily hematocrit and hemoglobin values (morning) were recorded. Eventually needed packed red blood cells transfusion units were recorded.

The professionals involved in the laboratory tests were blinded for the groups. The daily blood samplings were performed by trained personnel, in an attempt to minimize the initial volume loss in the control group. These intensive care units medical teams did already comply with a blood transfusion protocol. This trial had no interference with hemotherapy procedures.

Statistical analysis

The physiological variables were measured twice before the study enrollment. These variables mean was created for an inter-groups comparison. The entry and final Hb comparison was performed considering the last Hb value (discharge or death).

The physiological groups' variables were compared with the T Student test. Chronic diseases were analyzed as multiple responses, as one single patient could have more than one illness. The pairwise T Student test was used for pairwise Hb and Ht samples comparison between entry and final values. The 5% significance level was adopted a priori.

 

RESULTS

Were included 127 patients, 66 (52%) males and 61 (48%) females. The ICU stay length was 13.6 ± 10.54 days. Among comorbidities, the most frequent was cardiovascular disease, in 48.8% patients. Nineteen patients (15%) had single-lumen central line catheter, 85 (66.9%) had double-lumen center line catheter, and 110 (87%) had MBP catheter.

Regarding patients' demographics, comorbidities and physiological variables, both groups were similar, with no mean or median differences, nor on each variable patients' rates (Table 1).

Both groups had statistically significant Hb drops during their ICU stay (10.5 ± 2.24 to 9.1 ± 1.80, p=0.002 and VAMP group 10.4 ± 2.37 to 9.7 ± 1.3, p=0.012). However, the final Hb and Hb inter-groups comparisons showed a difference, with higher Hb and Ht values for the VAMP group (Table 1).

The total blood transfusions were observed for 14 days. The sum of all transfusions and mean transfusions per patient in each transfusion day were compared, with no significant inter-groups difference (Table 2). A dichotomized variable was created to evaluate at least one transfusion versus none, considering all transfusions during the observation period. The inter-groups transfusions frequency was compared with the Chi-Square test. There was no difference regarding transfusion rate between the groups (p=0.158), although the VAMP group had an absolute 12% transfusions reduction (Figure 1).

 

DISCUSSION

This trial has shown that the use of a closed blood sampling system was not able to prevent blood transfusions, however the hemoglobin and hematocrit values were higher in the closed system group.

Additionally, during the ICU stay the Hb and Ht values were observed to drop, with significant differences between the entry and final values. Several studies have shown increased anemia risk for patients staying longer in the ICU, added to the high disorder prevalence by the admission time.(10-12)

Severely ill patient's anemia is characterized by reduced erythropoetin production, an iron metabolism abnormality identical to the described for chronic illness and excessive loss anemia.(13-14) ICU anemia cause is multifactorial, including excessive phlebotomy for laboratory testing, active bleeding or losses such as hemodyalisis renal failure and erythropoiesis reduction.(15) In turn, these patients' erythropoiesis also involves several causes, including inflammatory, iron and vitamins deficiency and the underlying disease.(16-21)

Nevertheless, the final Ht and Hb inter-groups difference was significant, with higher Hb and Ht for the VAMP group. The studies trying this device failed to show this difference, although reducing the iatrogenic blood loss. Peruzzi et al. concluded that the blood discarded in patients not using a closed system is an independent predictor of Hb decline.(22,23)

Hebert et al. (1999) showed that a restrictive transfusion strategy is as effective and possibly superior to a liberal strategy, except for acute myocardial infarction and unstable angina patients. However, more recent studies have shown that about 40% to 50% of the ICU admitted patients receive at least one packed red blood cells transfusion, with a mean 5 units/patient transfused during the ICU stay, and the pre-transfusion hemoglobin around 8.5 g/dL.(10,24-27) Bearing in mind the hemotherapy-related effects and their negative impact on the outcome,(4,5,28-43) measures for minimizing transfusion should be encouraged.

Attention should be given to the phlebotomy, considering this practice as causative of anemia in the severely ill patient. Studies by Smoller and Kruskall identified that about one half of the transfused patients had lost in blood samplings almost the equivalent to one packed blood cells unit, and this was confirmed in other studies documenting 40 to 70 mL daily losses.(10,44-47) Thus, this situation may be minimized with lower blood volume phlebotomies, and with closed sampling systems, measures encouraged by trials proving relevant blood losses spare.(22,23,45,47) This, bearing in mind the importance of bringing the restrictive transfusion strategy to the clinical practice.

In agreement with current literature data, in this trial, when comparing the transfusion need, no reduction was identified with the device.(22-23,47) Perhaps this trial failed to show this reduction because its limitations, such as reduced sample size, insufficiently powered for this. To show a difference in the transfusions amount, at least 400 patients would be needed, which was unfeasible for the institution-determined study time, due to insufficient material availability.

Another limitation was not measuring the amount of patients' spoiled blood during samplings, in addition to measuring transfusions in units and not milliliters, as the bags had different volumes. In addition Hb values were not checked before each transfusion, a possible bias. However we understand that this does not invalidate our findings, as both groups had a single blood transfusions protocol.

 

CONCLUSION

The use of a closed blood sampling system was able to minimize the blood counts values drops, however failed to reduce transfusions. Larger trials are warranted to better evaluate these data consistency.

 

REFERENCES

1. Russell JA, Phang PT. The oxygen delivery/consumption controversy. Aapproaches to management of the critically ill. Am J Respir Crit Care Med. 1994;149(2 Pt 1):533-7.

2. Silva JM Jr, Toledo DO, Magalhães DD, Pinto MA, Gulinelli A, Sousa JM, et al. Influence of tissue perfusion on the outcome of surgical patients who need blood transfusion. J Crit Care. 2009;24(3):426-34.

3. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, et al. Perioperative blood transfusion and postoperative mortality. JAMA. 1998;279(3):199-205.

4. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts--blood transfusion. N Engl J Med. 1999;340(6):438-47. Review.

5. Park KW, Chandhok D. Transfusion-associated complications. Int Anesthesiol Clin. 2004;42(3):11-26.

6. Silva JM Jr, Cezario TA, Toledo DO, Magalhaes DD, Pinto MA, Victoria LG. Complications and prognosis of intraoperative blood transfusion. Rev Bras Anestesiol. 2008;58(5):454-61,447-54.

7. Schare M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med. 2003;31(12 Suppl):S651-7. Review.

8. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in ICU. Is there a reason? Chest. 1995;108(3):767-71.

9. Vicent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499-507.

10. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409-17. Erratum in: N Engl J Med 1999;340(13):1056.

11. Napolitano LM, Corwin HL, Fink MP, editors. Anemia in critical care: Etiology, treatment and prevention. Crit Care. 2004;8 Suppl 2:S1-S64.

12. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52.

13. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-23. Review.

14. Sihler KC, Napolitano LM. Anemia of inflammation in critically ill patients. J Intensive Care Med. 2008;23(5):295-302.

15. Walsh TS, Saleh EE. Anemia during critical illness. Br J Anaesth. 2006;97(3):278-91.

16. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16(1):36-41.

17. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL. Erythropoietin response is blunted in critically ill patients. Intensive Care Med. 1997;23(2):159-62.

18. Escobar GA, Cheng AM, Moore EE, Johnson JL, Tannahill C, Baker HV, et al. Stored packed red blood cell transfusion up-regulates inflammatory gene expression in circulating leukocytes. Ann Surg. 2007;246(1):129-34.

19. Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman CC. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. Shock. 2000;13(1):29-33.

20. Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ, Silliman CC. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: abrogation by poststorage washing but not prestorage leukoreduction. J Trauma. 2001;50(3):426-31; discussion 432.

21. Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol. 2008;15(3):169-75.

22. Peruzzi WT, Parker MA, Lichtenthal PR, Cochran-Zull C, Toth B, Blake M. A clinical evaluation of a blood conservation device in medical intensive care unit patients. Crit Care Med. 1993;21(4):501-6

23. MacIsaac CM, Presneill JJ, Boyce CA, Byron KL, Cade JF. The influence of a blood conserving device on anemia in intensive care patients. Anaesth Intensive Care. 2003;31(6):653-7.

24. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52.

25. Shapiro MJ, Gettinger A, Corwin H, Napolitano L, Levy M, Abraham E, et al. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma. 2003;55(2):269-73; discussion 273-4.

26. Rao MP, Boralessa H, Morgan C, Soni N, Goldhill DR, Brett SJ, Boralessa H, Contreras M; North Thames Blood Interest Group. Blood component use in critically ill patients. Anaesthesia. 2002;57(6):530-4.

27. Palmieri TL, Caruso DM, Foster KN, Cairns BA, Peck MD, Gamelli RL, Mozingo DW, Kagan RJ, Wahl W, Kemalyan NA, Fish JS, Gomez M, Sheridan RL, Faucher LD, Latenser BA, Gibran NS, Klein RL, Solem LD, Saffle JR, Morris SE, Jeng JC, Voigt D, Howard PA, Molitor F, Greenhalgh DG; American Burn Association Burn Multicenter Trials Group. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med. 2006;34(6):1602-7.

28. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132(6):620-4; discussion 624-5.

29. Zallen G, Offner PJ, Moore EE, Blackwell J, Ciesla DJ, Gabriel J, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 1999;178(6):570-2.

30. Taylor RW, O'Brien J, Trottier SJ, Manganaro L, Cytron M, Lesko MF, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med. 2006;34(9):2302-8; quiz 2309.

31. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30(10):2249-54.

32. Shorr AF, Jackson WL. Transfusion practice and nosocomial infection: assessing the evidence. Curr Opin Crit Care. 2005;11(5):468-72.

33. Shorr AF, Duh MS, Kelly KM, Kollef MH; CRIT Study Group. Red blood cell transfusion and ventilator-associated pneumonia: A potential link? Crit Care Med. 2004;32(3):666-74.

34. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion. 1996;36(2):175-86.

35. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 2002;68(7):566-72.

36. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev. 2002;16(2):144-60.

37. Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev. 2001;15(2):108-35.

38. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97(5):1180-95. Review.

39. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287(15):1968-71.

40. Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med. 2006;34(5 Suppl):S109-13.

41. Rana R, Fernández-Pérez ER, Kahn SA, Rana S, Winters JL, Lesnick TG, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion. 2006;46(9):1478-83.

42. Li G, Daniels CE, Kojicic M, Krpata T, Wilson GA, Winters JL, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion. 2009;49(1):13-20.

43. Skeate RC, Easlung T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol. 2007;14(6):682-7.

44. Fowler RA, Rizoli SB, Levin PD, Smith T. Blood conservation for critically ill patients. Crit Care Clin. 2004;20(2):313-24, x.

45. Smoller BR, Kruskall MS. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med. 1986;314(19):1233-5.

46. Tarpey J, Lawler PG. Iatrogenic anaemia? A survey of venesection in patients in the intensive therapy unit. Anaesthesia. 1990;45(5):396-8.

47. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, Hebert PC, Anderson GL, Bard MR, Bromberg W, Chiu WC, Cipolle MD, Clancy KD, Diebel L, Hoff WS, Hughes KM, Munshi I, Nayduch D, Sandhu R, Yelon JA; American College of Critical Care Medicine of the Society of Critical Care Medicine; Eastern Association for the Surgery of Trauma Practice Management Workgroup. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009;37(12):3124-57.

 

 

This trial was conducted at Hospital do Servidor Público Estadual "Francisco Morato de Oliveira" HSPE-FMO - São Paulo (SP), Brazil, Hospital São Francisco -Ribeirão Preto (SP), Brazil and Hospital de Emergência e Trauma Senador Humberto - João Pessoa (PB), Brazil.

 

 

Submission On-line

Indexed in

Scopus

SciELO

LILACS

Associação de Medicina Intensiva Brasileira - AMIB

Rua Arminda nº 93 - 7º andar - Vila Olímpia - São Paulo, SP, Brasil - Tel./Fax: (55 11) 5089-2642 | e-mail: [email protected]

Cookie Policy

GN1 - Systems and Publications